A Form 4 filed on November 10, 2026 by Stacy Lindborg, President and CEO of Imunon, Inc., disclosed the acquisition of 3,804 shares of common stock on November 6, 2026, granted in lieu of cash for a portion of her base salary.

Key Highlights

  • Reporting person: Stacy Lindborg, President and CEO and Director of Imunon, Inc.
  • Transaction: 3,804 shares of common stock acquired (transaction code A) on November 6, 2026 at a price of $0.845 per share.
  • Nature of grant: According to the filing, shares were "stock granted in lieu of cash for portion of base salary."
  • Direct beneficial ownership following transaction: 122,581 shares held directly.
  • Indirect ownership: An additional 778 shares held indirectly through a 401(k) Plan.
  • Filing signed by: Jeffrey W. Church, Attorney in Fact for Stacy R. Lindborg, on November 10, 2026.

Lindborg's November 2026 Salary-in-Stock Transaction at Imunon

According to the Form 4 filed with the SEC on November 10, 2026, Stacy Lindborg, who serves as both President and CEO and as a Director of Imunon, Inc. (NASDAQ:IMNN), reported the acquisition of 3,804 shares of Imunon common stock on November 6, 2026. The filing identifies the transaction code as "A" (acquired) and lists the per-share price as $0.845. A footnote in the filing states that the shares were "stock granted in lieu of cash for portion of base salary," indicating the acquisition reflects a compensation arrangement rather than an open-market purchase.

Following this transaction, the filing reports that Lindborg directly owns 122,581 shares of Imunon common stock. In addition, the filing discloses 778 shares held indirectly through a 401(k) Plan. No derivative securities transactions were reported in Table II of the filing. The form was signed by Jeffrey W. Church as Attorney in Fact for Stacy R. Lindborg.

What Was Disclosed

The filing disclosed a single acquisition of 3,804 Imunon common shares by CEO Stacy Lindborg on November 6, 2026, at $0.845 per share in lieu of cash salary, bringing her direct beneficial ownership to 122,581 shares, with 778 additional shares held via a 401(k) Plan.